Evidence map›Paper›PMID 27392855›Full record

ArticleJournal of Alzheimer's disease : JAD2016

Interaction Between Midlife Blood Glucose and APOE Genotype Predicts Later Alzheimer's Disease Pathology.

Katherine J Bangen, Jayandra J Himali, Alexa S Beiser, Daniel A Nation, David J Libon, Caroline S Fox, Sudha Seshadri, Philip A Wolf, Ann C McKee, Rhoda Au and 1 more

Abstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. APOE and immunity: Research highlights.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Cognitive resilience among APOE ε4 carriers in the oldest old.International journal of geriatric psychiatry · 2019
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Katherine J BangenResearch Service, Veterans Affairs San Diego Healthcare System, San Diego, CA, USA.
Jayandra J HimaliDepartment of Neurology, Boston University School of Medicine, Boston, MA, USA.
Alexa S BeiserDepartment of Neurology, Boston University School of Medicine, Boston, MA, USA.
Daniel A NationDepartment of Psychology, University of Southern California, Los Angeles, CA, USA.
David J LibonDepartment of Geriatrics and Gerontology, Rowan University School of Osteopathic Medicine, Stratford, NJ, USA.
Caroline S FoxThe Framingham Heart Study, Framingham, MA, USA.
Sudha SeshadriDepartment of Neurology, Boston University School of Medicine, Boston, MA, USA.
Philip A WolfDepartment of Neurology, Boston University School of Medicine, Boston, MA, USA.
Ann C McKeeDepartment of Neurology, Boston University School of Medicine, Boston, MA, USA.
Rhoda AuDepartment of Neurology, Boston University School of Medicine, Boston, MA, USA.
Lisa Delano-WoodResearch Service, Veterans Affairs San Diego Healthcare System, San Diego, CA, USA.
Boston University · USVA San Diego Healthcare System · USBrigham and Women's Hospital · USRowan University · USUniversity of Southern California · US

Funding

Neuropathology CoreP30AG013846 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI KOWALL, NEIL W. · 1996 to 2020
$29.1M
UC Davis Alzheimer's Disease Core CenterP30AG010129 · NIA · UNIVERSITY OF CALIFORNIA DAVIS · PI DECARLI, CHARLES · 1991 to 2020
$28.3M
PRECURSORS OF STROKE INCIDENCE AND PROGNOSISR01NS017950 · NINDS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Hugo Javier Aparicio, Jose Rafael Romero · 1985 to 2026
$22.9M
EPIDEMIOLOGY OF DEMENTIA IN THE FRAMINGHAM STUDYR01AG008122 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI AU, RHODA, SESHADRI, SUDHA · 1989 to 2015
$14.4M
MRI, Genetics &Cognitive Precursors of AD &DementiaR01AG016495 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI AU, RHODA · 1999 to 2016
$12.5M
MRI, Cognitive, Genetic & Biomarker Precursors of AD & Dementia in Young AdultsR01AG033040 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI AU, RHODA, SESHADRI, SUDHA · 2009 to 2019
$11.2M
Neuroimaging and Risk Factor Correlates in Aging and MCIK24AG026431 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BONDI, MARK W · 2007 to 2016
$1.7M
Vascular Reserve and Protective Mechanisms in Aging and Alzheimer’s Dementia RiskR21AG055034 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI NATION, DANIEL A · 2017 to 2018
$454k
THE FRAMINGHAM HEART STUDY-N01HC25195-268025195-268025195N01HC025195 · HC · TRUSTEES OF BOSTON UNIVERSITY · PI WOLF, PHILIP A · 2002 to 2006
–
Neuroimaging and Vascular Correlates of Mild Cognitive Impairment SubtypesIK2CX000938 · VA · VA SAN DIEGO HEALTHCARE SYSTEM · PI BANGEN, KATHERINE · 2015 to 2019
–
CSRD VA IK2 CX000938NHLBI NIH HHS N01 HC025195NIA NIH HHS K24 AG026431NIA NIH HHS P30 AG010129NIA NIH HHS P30 AG013846NIA NIH HHS R01 AG008122NIA NIH HHS R01 AG016495NIA NIH HHS R01 AG033040NIA NIH HHS R21 AG055034NINDS NIH HHS R01 NS017950
6 · The paper itself

Abstract

Elevated blood glucose and the apolipoprotein (APOE) ɛ4 allele have both been associated with increased dementia risk; however, the neuropathological mechanisms underlying these associations remain unclear. We examined the impact of APOE genotype and midlife blood glucose on post-mortem vascular and Alzheimer's disease (AD) neuropathology. Ninety-four participants from the Framingham Heart Study without diagnosed diabetes underwent health examination at midlife and brain autopsy at death. Histopathological measures of vascular and AD neuropathology were obtained and analyzed. Results demonstrated that, among APOE ɛ4 carriers, elevated blood glucose was associated with more severe AD pathology. There was no such relationship with vascular pathology. In a relatively healthy sample with low vascular risk burden, midlife elevated blood glucose was associated with greater AD pathology among APOE ɛ4 carriers. A better understanding of interactive effects of APOE genotype and vascular risk on neuropathology has implications for identification of individuals at risk for decline and long-term preventive treatment.

Indexed as

Alzheimer DiseaseBlood GlucoseApolipoprotein E4BrainCohort StudiesFemaleGenotypeHumansMaleMiddle AgedNeurofibrillary TanglesNeuropsychological TestsPredictive Value of TestsRisk FactorsVascular DiseasesApolipoprotein E4Blood GlucoseAlzheimer’s diseaseapolipoprotein E (APOE)diabetesglucoseneuropathologyvascular risk

Identifiers

PMID27392855
PMCPMC5494258
OpenAlexW2465411907

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.